Arcturus Therapeutics Holdings Inc
ARCT
Get informed when a big investor buys or sells
+ FollowMarket Cap$171.96M
Close$
$-5.96
203% downside
Current Fair Value
203% downsideOvervalued by 203% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $171.96 Million |
|---|---|
| Enterprise Value | $-12,125,433.00 |
| Dividend Yield | $0.68 (-) |
| Earnings per Share | $-2.4 |
| Beta | 2.36 |
| Outstanding Shares | 28,421,000 |
Return
| Return on Equity | -26.01% |
|---|---|
| Return on Assets | -20.28% |
| Return on Invested Capital | -41.14% |
Valuation & Multiples
| P/E Ratio | -2.14 |
|---|---|
| PEG | 1.88 |
| Price to Sales | 5.79 |
| Price to Book Ratio | 0.97 |
| Enterprise Value to Revenue | -0.28 |
| Enterprise Value to EBIT | 0.14 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -2.25 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-1.01
Average shareholder expectationRevenue Estimate
$6.30 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-1.00
Average shareholder expectationRevenue Estimate
$3.11 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 79.79% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.47%▼ 87.22% |
|---|---|
| Total Invested | $2.83M▼ 98.49% |
| Investors Holding | 10▼ 120.00% |
ESG Score
No data